Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00849823 · ClinicalTrials.gov registry record · NA

HIV Prevention Program for African American Teen Males

A NA study of HIV Infections and Sexually Transmitted Infections, sponsored by Richard Crosby.

Completed
Registry status
NA
Development phase
840
Enrollment target
1
Study location

NCT00849823 is a NA study of HIV Infections and Sexually Transmitted Infections that has completed, run by Richard Crosby. The registered enrollment target is 840 participants, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (89% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00849823, a NA study of HIV Infections and Sexually Transmitted Infections, has completed, sponsored by Richard Crosby.

COMPLETED
Registry status
NA
Development phase
840 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test if sexual health interventions can reduce the incidence of STIs among African American teens (15 to 21 years old). By doing this study, we hope to help African American teens improve their condom use skills and encourage them to use condoms more frequently. If the number of STIs in this population can be decreased, the health of African American teen males will greatly improve. We also believe that sexual partners (typically African American teen females) will also benefit.

Interventions

  • BEHAVIORAL Male Sexual Health Program
  • BEHAVIORAL Focus on the Future Program

Study Locations (1)

Louisiana

  • Adolescent Medicine Program, LSU School of Medicine - New Orleans

Trial Details

FieldValue
Enrollment Target 840 participants
Start Date 2009-02
Est. Completion 2013-09
Phase NA

Sponsor

Richard Crosby

3 total trials

What the Registry Record Tells You About NCT00849823

The ClinicalTrials.gov registry entry for NCT00849823 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 840 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (89% higher). The listed sponsor is Richard Crosby, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Male Sexual Health Program is the first listed.

NCT00849823 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT00849823 about?

NCT00849823 is a clinical study titled "HIV Prevention Program for African American Teen Males". The purpose of this study is to test if sexual health interventions can reduce the incidence of STIs among African American teens (15 to 21 years old). By doing this study, we hope to help African American teens improve their condom use skills and encourage them to use condoms more frequently. If th...

What is the current status of trial NCT00849823?

This trial is currently completed. It is a NA study. The enrollment target is 840 participants. The study started on 2009-02. Estimated completion is 2013-09.

What conditions does trial NCT00849823 study?

This clinical trial studies the following conditions: HIV Infections, Sexually Transmitted Infections.

What interventions are being tested in trial NCT00849823?

The interventions under investigation include: Male Sexual Health Program (BEHAVIORAL), Focus on the Future Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT00849823?

This trial is sponsored by Richard Crosby, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00849823 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.